The Rutgers research and innovation community came together to celebrate its own at the 2023 Patent Celebration, in Trayes Hall at the Douglass Student Center.
Late Joachim Messing Receives Science and Technology Medal from R&D Council of New Jersey for His Groundbreaking Work as Translational Scientist
Internationally renowned Rutgers University scientist and former director of the Waksman Institute of Microbiology, Joachim Messing, was posthumously honored as this year’s recipient of the Science and Technology Medal from the Research & Development Council of New Jersey for his groundbreaking work in shotgun DNA sequencing.
Rutgers Office for Research is honoring Women’s History Month by highlighting researchers from each of the university’s four campuses: Rutgers Biomedical and Health Sciences (RBHS), Camden, Newark, and New Brunswick. These five women, and the impressive work they do every day to make the world a better place, represent the best of Rutgers; the diverse faculty and the variety of research conducted within, inclusive of STEM, arts, humanities and the social sciences.
To celebrate Black History Month, the Office for Research is highlighting some of the many researchers from across Rutgers, The State University of New Jersey who are making an impact on the university and their field of study. The vital work being conducted represents the diversity of research within Rutgers, which is inclusive of STEM, arts, humanities and the social sciences. The faculty members featured in this Q&A story are not just leaders in their fields; they also represent the notions of diversity, equity, and inclusion that the university and the Office for Research strive to uphold.
Rutgers Office for Research Signs Exclusive License with SoftGenetics, LLC to Market Innovative DNA Analysis Technology
Rutgers Office for Research has signed an exclusive license with SoftGenetics, LLC for the company to commercialize innovative software technology developed by Rutgers-Camden professors Catherine Grgicak, PhD and Desmond Lun, PhD. The technology, called NOCIt, is a computational tool that calculates the probability of the number of contributors in a DNA profile.
The broad aim of Ngwa’s research and global collaboration is to increase access to cancer treatment and reduce health disparities, particularly in low- and middle-income countries. He leads a research group developing low-cost approaches and technologies that can substantially reduce treatment times and costs and be implemented in resource-poor settings.